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INTRODUCTION
The simultaneous occlusion of two coronary arteries inthe setting of ST elevation myocardial Infarction is a rareoccurrence and is estimated to occur in 2.5% of allprimary PCI patients.1
Occasionally, such multivessel occlusions of coronaryvessels can be at areas where stenting might not befeasible due to very small vessel or very distal vesselocclusion. These lesions pose a unique challenge to theinterventional cardiologist. We, herein, report such acase of a patient with simultaneous distal occlusion oftwo coronary arteries in the setting of ST elevationmyocardial infarction that were dealt with intracoronarystreptokinase upfront separately in each vessel forrestoration of flow, followed by glycoprotein (GP) IIb/IIIainhibitors infusion and then Factor Xa inhibitor(Rivaroxaban) with full recovery of patient.
CASE REPORT
A 57-year gentleman presented to the Aga KhanUniversity Hospital, Karachi, Pakistan in May 2015 withKillip I Inferoposterior lateral STEMI (Figure 1A). STsegments did not show any response to sublingualnitrates in emergency room. His baseline investigationsare shown in Table I. He was transferred to the cath labfor emergent coronary angiogram that showedsimultaneous occlusion in distal left circumflex artery
(LCx) and apical left anterior descending artery (LAD).As the patient had borderline blood pressures,intracoronary nitroglycerin (IC GTN) was not given torule out spontaneous coronary spasm. Due to the verydistal location of the lesions, it was decided to useintracoronary streptokinase (SK) for revascularisation.250KU intracoronary SK was injected sequentially intothe LAD and LCx over 3 minutes via aspiration catheter.Post-intracoronary SK, TIMI III flow was seen both indistal LAD and LCx (Figure 2). The ECG changes settled
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ABSTRACTThe occurrence of distal coronary lesions causing simultaneous occlusion of two coronary arteries in the setting of STelevation myocardial infarction is a rare occurrence. This can occur due to simultaneous plaque rupture at more than onesite or embolisation in coronary arteries. We describe a case of a middle-aged man who presented with acuteinferoposterior lateral wall ST elevation myocardial infarction with simultaneous occlusion of distal left anterior descendingartery and distal left circumflex artery on angiogram. The patient was treated with intracoronary streptokinase, followed byglycoprotein (GP) IIb/IIIa inhibitor and Factor X inhibitor (Rivaroxaban) with full resolution of flow in the distal vessels.Thus, coronary lesions, not amenable to stenting, can be dealt percutaneously, using a combination of old and newerpharmacological agents without stenting.
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Table I: Investigations at admission.
Investigations Result Normal Lab value
Hemoglobin 14.8 g/dl 12.0-15.0 g/dl
Platelets 290x109/L 150-300x109/L
Creatinine 0.9 mg/dl Less than 1.2 mg/dl
(Figure 1B) and the patient became pain-free. Patientwas started on GP IIb/IIIa inhibitor infusion for 24 hoursand then on tablet Rivaroxaban 10 mg twice daily. Thepatient remained symptom-free during hospital stay. Atrans-esophageal echocardiograph (TEE) was donewhich showed no evidence of vegetation or clot. A relookangiogram was done prior to discharge that showedTIMI III flow in LAD and LCx. The patient was dischargedon dual antiplatelets (DAPTs) and Rivaroxaban 15 mgonce daily. Rivaroxaban was continued for 3 months andthen he was kept on DAPTs. At one year follow-up, thepatient is asymptomatic with full recovery of left ventriclefunction on echocardiograph.
DISCUSSION
Review of literature shows that simultaneous occlusionof more than one coronary vessel causing STEMI isunusual and often lethal associated with cardiogenicshock and high mortality.1,2 Simultaneous occlusion ofmore than one coronaries may occur due to plaquerupture, embolisation, coronary spasm, hypercoagulablestates such as malignancy, thrombocytosis andantithrombin III deficiency.3,4 Most of these patients arehemodynamically unstable with high incidence ofcardiogenic shock and chances of life-threateningventricular arrhythmias.5
A review of literature on the use of thrombolytics in thesetting of STEMI with simultaneous multivesselocclusions on coronary angiogram shows four caseswhich were dealt with intracoronary (IC) thrombolytics(Table II). In these cases, use of IC thrombolytics wasreserved with stenting, mostly for proximal coronaryartery lesions. The most common combination forsimultaneous occlusions of vessels was LAD and rightcoronary artery (RCA). Urokinase appeared as thethrombolytic agent of choice.6-8 To our knowledge, thereis no reported case where an IC thrombolytic therapywith SK was used for distal occlusions in the setting ofSTEMI caused by simultaneous occlusion of more thanone coronary vessels.
Though, IC SK was used in the pre-stenting era, but itsuse was associated with complications such as systemic
Non-stenting approach for distal coronary occlusion
Figure 2: Coronary angiogram: (A) RAO caudal view showing occlusion ofdistal LAD and LCx branches; (B) RAO cranial view showing occlusion ofdistal LAD and LCx branches; (C) Intracoronary streptokinase injection intoleft circumflex artery; (D) Intracoronary streptokinase injection into leftanterior descending artery; (E) RAO caudal view after intracoronarystreptokinase showing flow in distal LAD and LCx; (F) RAO cranial view afterintracoronary streptokinase showing flow in distal LAD and LCx.
Figure 3: (A) Coronary angiogram pre-intracoronary streptokinase; (B) Post-intracoronary streptokinase.
Table II: Review of case reports of patients with ST elevation myocardial infarction with simultaneous occlusion of two coronary arteries treatedwith intracoronary thrombolytics.
Study Year Age Presentation Vessel involved Treatment Dose of intracoronary Immediate results Outcomethrombolytics of intervention
Hamada [11] 1989 59 Inferior STEMI Proximal left anterior Intracoronary urokinase 720,000 IU to RCA 60% residual stenosis Alivedescending and  right to LAD and RCA 480,000 IU to LAD in RCA, 50% residualcoronary artery stenosis in LAD
Yoshitomi [12] 1998 34 Anterolateral STEMI Proximal left anterior Stenting of LAD and 3,000 IU to LCx 30% distal stenosis in Alivedescending and proximal Intracoronary prourokinase LAD  and LCXleft circumflex coronary to LCxartery
Hosokawa [13] 2001 33 Inferolateral STEMI Proximal left anterior Stenting of RCA and 6,400,000 IU TIMI III flow in RCA, Alivedescending and mid Intracoronary tisokinase LAD showed residual right coronary artery in LAD thrombus
Turgeman [14] 2007 44 Anteroinferior STEMI Proximal left anterior Thrombus aspiration 125,000 IU TIMI III flow in LAD Alivewith cardiogenic shock descending and proximal followed by intracoronary  and RCAright coronary artery urokinase in the left andright coronary system
*RCA = Right coronary artery;   LAD = Left anterior descending artery;   LCx = Left circumflex artery;   IU = International units;   STEMI = ST elevation myocardial infarction.
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bleeding and bleeding at the puncture site. Thesecomplications were more pronounced if dose of SKexceeded 200,000 IU. The other major cardiaccomplications of IC SK administration were reperfusionarrhythmias. With the advent of stenting, the use of ICSK became limited. However, in 2007, Murat in his studyused IC SK after stenting in patients undergoing primarypercutaneous intervention.9 The dose used by Murat et al.was 250 KU, at which the chances of SK associatedcomplications were significantly low. However, in thatstudy IC SK was used after stenting to achieve betterflow. The authors used this dose of SK (250KU)separately for each vessel upfront without anycomplications. This case showcases the fact that thisdose of SK can be used safely in more than one vesselocclusion.
This case report is an unusual occurrence of STEMI withsimultaneous mutlivessel occlusions that might haveoccurred because of possible simultaneous plaquerupture in multiple coronary arteries or due toembolisation of a proximal clot. In the patient, the TEEdid not show any evidence of proximal clot; however, thepossibility of clot embolisation from a proximal sourcecannot be ruled out completely. An intravascularultrasound (IVUS) might have helped in delineating theetiology. However, due to the distal location of lesions, itwas not performed during the angiogram. The historyand laboratory workup did not suggest any hyper-coagulable state. Another differential was spontaneouscoronary spasm in the distal vessels; however, patientdid receive sublingual nitrates in emergency room, butdue to low blood pressure during the procedure, IC GTNcould not be used. Furthermore, we found in ourprocedure that flow was only restored after fibrinlolytictherapy suggesting a thrombotic event rather thanspasm. Other possibility in this case was spontaneousplaque rupture occurring at more than one distinct sitesimultaneously leading to ST-elevation myocardialinfarction. Therefore, to prevent re-occlusion of arteries,we decided to keep our patient initially on GP IIb/IIIainhibitors and then on Rivaroxaban for few months.
Rivaroxaban, a coagulation Factor Xa inhibitor, is approvedfor use in nonvalvular atrial fibrillation for the preventionof stroke and systemic embolism. However, in patientswith acute coronary syndromes, low-dose Rivaroxabanis known to reduce the risk of the composite end-point ofdeath from cardiovascular causes, myocardial infarction,or stroke.10 As spontaneous plaque rupture at multiplesites was suspected in our patient, we used a higherdose of Rivaroxaban. This approach helped in our
patient's management without recurrence of any clinicalevents and full recovery of left ventricular function.
This case is unique in which there was simultaneousocclusion of two distal vessels, which were dealt withold (SK, DAPTs and GP IIb/IIIa) inhibitors and newpharmacological agents (Rivaroxaban) combined withpercutaneous intervention for full recovery of patient. 
Though rare, ST-segment elevation myocardial infarctionwith simultaneous multiple coronary artery occlusionsmay occur. In patients with distal coronary lesions notamenable to stenting, the use of IC SK initially and thenfollowed by GP IIb/IIIa inhibitors and newer anti-coagulants based on clinical condition and risk factors ofpatients can provide good immediate angiographicresults with full recovery of left ventricular function inthese patients on follow-up.
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